SOURCE Inovio Pharmaceuticals, Inc.
Jim Cramer takes a closer look at Inovio Pharmaceuticals, a small biotech developing DNA-based immunotherapies to treat cancer.
Jim Cramer says the story is less about Comey vs. Trump than it is about Nvidia vs. Nordstrom.
NewLink Genetics, Inovio Pharmaceuticals and Juno Therapeutics were among the biotech stock movers in premarket trading on Thursday.
Finding bullish and bearish reversals in the market.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.